Intelligence Platform
Patents
Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11654142
Methods for the administration of certain VMAT2 inhibitors
granted patentUS 11649251
Substituted inhibitors of menin-MLL and methods of use
granted patentUS 11643388
Inhibitors of alpha 2 beta 1 integrin and methods of use thereof
granted patentUS 11639355
Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors
granted patentUS 11639364
Potent sialyltransferase inhibitors
granted patentUS 11634413
Neprilysin inhibitors
granted patentUS 11629145
SHP2 phosphatase inhibitors and methods of use thereof
granted patentUS 11622970
BCL-2 inhibitors and their use as pharmaceuticals
granted patentUS 11618731
Prodrugs of kallikrein inhibitors
granted patentUS 11618746
Inhibitors of APOL1 and methods of using same
granted patentUS 11617742
Methods of treating keratin hyperproliferation disorders using mTOR inhibitors
granted patentUS 11613528
Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use
granted patentUS 11613527
Enzyme inhibitors
granted patentUS 11608346
Ras inhibitors
granted patentUS 11607414
Small molecule inhibitors of EGFR and PI3K
granted patentUS 11597727
Inhibitors of integrin alpha 2 beta 1 and methods of use
granted patentUS 11591304
SLC26A3 inhibitors and use thereof
granted patentUS 11591336
Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors
granted patentUS 11584758
RIP1K inhibitors
granted patentUS 11584733
Selective histone deacetylase inhibitors for the treatment of human disease
granted patentUS 11583538
Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors
granted patentUS 11576922
CD73 inhibitors
granted patentUS 11576948
Long-acting VEGF inhibitors for intraocular neovascularization
granted patentUS 11566007
Ras inhibitors
granted